Search

everythinglearnresearchcommunity

for

Search:↓

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Ozenoxacin reduces sebum production, helping manage acne.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

Janus kinase inhibitors may help treat lichen planopilaris.

Hydroxychloroquine helped improve scleromyxoedema in patients, but caused side effects in some.

The diphosphonate was the most effective at preventing calcification in rats.

Retinoids or their analogs could treat skin pigmentation disorders like melasma and vitiligo.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Hyaluronic acid increases collagen synthesis safely, while poly-L-lactic acid may cause complications by affecting fibroblasts.

Mutations in the LIPH gene cause woolly hair in a child.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

L-Lysine may help with various health conditions, but results are inconsistent for herpes treatment and its potential in other therapies is still being explored.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

CTP-543 is generally safe for treating alopecia areata.

A Turkish woman has a hair condition caused by a LIPH gene mutation.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Upadacitinib may effectively treat resistant lichen planopilaris.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Baricitinib may effectively treat oral lichen planus.